18 February 2026
18 February 2026
Industry and US administration leaders lay out their plans to navigate a globally competitive pharma landscape with China’s growing dominance.
The UK was the highest ranked country for those offshoring pharma R&D, raising questions about its pharma industry’s attractiveness.
Respondents from a GlobalData survey have identified pricing and reimbursement hurdles as one of the top three challenges facing the pharma sector over the next year.
The therapy dosing provides clinical outcomes consistent with those of the earlier approved bi-weekly subcutaneous regimen.
The anticipated growth is mainly driven by ten new pipeline drugs expected to be introduced to the market by 2034.
The partnership will combine Evogene’s computational chemistry capabilities with the expertise of a team at QUT.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
